Related Experiment Video
Updated: May 23, 2026

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
Published on: February 5, 2015
Organophosphorus compound effects on neurotrophin receptors and intracellular signaling
Melinda Pomeroy-Black1, Marion Ehrich
1Department of Biology, LaGrange College, 601 Broad Street, LaGrange, GA 30240, USA. mblack@lagrange.edu
Abstract:
Neurite outgrowth of SH-SY5Y neuroblastoma cells following the addition of spinal cord extracts from chickens exposed to a neuropathic organophosphorus (OP) compound suggests the presence of a growth factor during OP neuropathy. However, exposure of SH-SY5Y cells directly to neuropathic OP compounds results in apoptosis and/or decreased neurite outgrowth. These cellular effects may follow OP-induced interference with neurotrophin-receptor binding and/or intracellular signaling resulting from receptor binding. We hypothesized that sub-lethal concentrations of a neuropathic OP compound interferes with neurotrophin-receptor binding as well as specific intracellular signaling pathways in neuroblastoma cells which would not occur with a non-neuropathic OP compound. SH-SY5Y cells were exposed to a neuropathic OP compound (PSP; 0.01, 0.1, 1.0μM), a neuropathic OP compound with nerve growth factor (1.0μM PSP+1ng/ml NGF), a non-neuropathic OP compound (paraoxon; 100μM), and medium only for 4, 8, 24, and 48h. Western blots indicate that cells exposed to a low dose of PSP or the high dose of PSP+NGF contained the phosphorylated form of a common neurotrophin receptor (pp75) that was four times greater than that of the phosphorylated form of the high-affinity NGF receptor (pTrkA) suggesting that p75 activation may contribute to early cell death after exposure to OP compounds. Furthermore, events in signaling pathways after exposure to PSP differed from those after exposure to paraoxon, with activation of the MEK1/2 protein increasing significantly only after exposure to paraoxon. Both types of OP compounds, however, caused significant activation of Akt in the PI-3K cell-survival pathway. These results suggest that exposure to a non-neuropathic OP compound causes increased activity of the MAPK pathway whereas exposure to neuropathic OP compounds prevented upregulation of the pathway. Since this pathway is integral to neurite outgrowth and cell survival, this study has revealed molecular mechanisms implicated in neuronal response after exposure to neuropathic OP compounds.
Insights
Neuropathic organophosphorus (OP) compounds disrupt neurotrophin signaling and cell survival pathways in neuroblastoma cells, unlike non-neuropathic OPs. This study reveals molecular mechanisms behind neuronal responses to OP exposure.
Area of Science:
- Neuroscience
- Toxicology
- Cell Biology
Background:
- Organophosphorus (OP) compounds can cause neuropathy, affecting neuronal function.
- Neuropathic OPs induce apoptosis and decrease neurite outgrowth in neuroblastoma cells.
- OPs may interfere with neurotrophin-receptor binding and intracellular signaling.
Purpose of the Study:
- To investigate how sub-lethal concentrations of neuropathic OP compounds affect neurotrophin-receptor binding and intracellular signaling pathways.
- To compare the effects of a neuropathic OP (PSP) with a non-neuropathic OP (paraoxon) on SH-SY5Y neuroblastoma cells.
- To elucidate the molecular mechanisms underlying neuronal responses to OP exposure.
Main Methods:
- SH-SY5Y neuroblastoma cells were exposed to varying concentrations of PSP (neuropathic OP) and paraoxon (non-neuropathic OP).
- Cells were also treated with nerve growth factor (NGF) alongside PSP.
- Western blotting was used to analyze the phosphorylation status of neurotrophin receptors (pp75, pTrkA) and key signaling proteins (MEK1/2, Akt).
Main Results:
- PSP exposure, especially at low doses or with NGF, increased phosphorylated pp75 receptor levels, suggesting a role in early cell death.
- PSP exposure altered signaling pathways differently than paraoxon, with paraoxon activating MEK1/2, while PSP did not.
- Both OP compounds activated Akt in the PI-3K cell-survival pathway, but paraoxon increased MAPK pathway activity, which PSP exposure prevented.
Conclusions:
- Neuropathic OP compounds interfere with neurotrophin receptor signaling and inhibit MAPK pathway activation, crucial for neurite outgrowth and cell survival.
- Non-neuropathic OP compounds activate the MAPK pathway, indicating differential molecular mechanisms between neuropathic and non-neuropathic OPs.
- These findings reveal key molecular pathways involved in neuronal responses to neuropathic OP-induced toxicity.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Drugs Affecting Neurotransmitter Synthesis
Excitatory and Inhibitory Effects of Neurotransmitters
Parasympathetic Signaling
The effects of...
Neurochemical Transmission: Sites of Drug Action